Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

22nd Century Group, Inc - Common Stock (NQ:XXII)

0.6460 -0.0135 (-2.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 22nd Century Group, Inc - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Analysts' Take Brought To You On Monday's Cannabis Daily Podcast
The Best Daily Overview Of The Cannabis Space Village Farms Intl (NASDAQ: 
Via Benzinga
22nd Century Group, Inc. Common Stock Earnings Perspective: Return On Capital Employed
Benzinga Pro data, 22nd Century Group, Inc. Common Stock (AMEX:XXII) reported Q4 sales of $7.96 million. Earnings fell to a loss of $13.96 million, resulting in a 47.93% decrease... 
Via Benzinga
22nd Century Group: Q4 Earnings Insights
22nd Century Group (NASDAQ:XXII) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Earnings Preview: 22nd Century Group, Inc. Common Stock
22nd Century Group, Inc. Common Stock (AMEX:XXII) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the... 
Via Benzinga
22nd Century Group Welcomes Dr. Robert Califf's Confirmation As FDA Commissioner
22nd Century Group, Inc. (NASDAQ: XXII) an agricultural biotechnology company focused on tobacco harm reduction, congratulated Dr. Robert Califf on his confirmation as FDA... 
Via Benzinga
XXII Stock Alert: Why Is 22nd Century Group Soaring Higher Today?
Agricultural biotech company 22nd Century Group is celebrating an FDA designation. As a result, XXII stock is up 40% today. 
Via InvestorPlace
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
22nd Century Group To Host Q4 & FY 2021 Earnings Call
22nd Century Group, Inc. (NASDAQ: XXII) announced that it will host a live webcast on Tuesday, March 1, 2022, at 10:00 AM ET to discuss its 2021 fourth quarter and full year results. 
Via Benzinga
Cannabis Stock Gainers And Losers From February 2, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 7.14% at $1.20 
Via Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 
Via Benzinga
Cannabis Stock Gainers And Losers From January 27, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03 
Via Benzinga
Cannabis Stock Gainers And Losers From January 21, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 20, 2022
GAINERS: Icanic Brands (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 19, 2022
GAINERS: Heritage Cannabis Holding (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 18, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 13, 2022
GAINERS: MGC Pharmaceuticals (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 12, 2022
GAINERS: Cannabix Technologies (OTC: 
Via Benzinga
Cannabis Stock Gainers And Losers From January 5, 2022
GAINERS: Rhinomed (OTC: 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining 0.81% to 4,734.65. The U.S. has the... 
Via Benzinga
54 Biggest Movers From Thursday
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... 
Via Benzinga
Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
Midway through trading Thursday, the Dow traded up 0.62% to 35,975.34 while the NASDAQ rose 0.66% to 15,624.94. The S&P also rose, gaining 0.67% to 4,728.06. The U.S. has the... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.... 
Via Benzinga
Aurora Cannabis, 22nd Century Group To License Biosynthesis Intellectual Property To Cronos
Canadian marijuana titan Aurora Cannabis Inc. (NASDAQ:ACB) ... 
Via Benzinga
New Kid In Town — Cannabis Daily December 9, 2021
The Best Daily Overview Of The Cannabis Space Valens Co. Commences Trading on NASDAQ under symbol $VLNS Public co... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group
Leafly Hires Rebecca Warner As VP Of Sales The cannabis information platform Leafly Holdings, Inc. said Wednesday that... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Gainers BIMI International (NASDAQ:BIMI 
Via Benzinga
Chart: How Have Cannabis Industry Sectors Performed This Year And What Are Their Valuation Multiples? Do They Make Sense?
Viridian Capital Advisors breaks the cannabis industry down into 12 sub sectors for purposes of tracking capital raises, M&A activity, valuatio... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Canopy's Earnings, JPMorgan's Restrictions, A Slew Of Earnings, Big Policy Moves
Below is a recap of the main news related to the cannabis industry and markets for the week of November 1st, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines
Plant-based biotech company 22nd Century Group, Inc. (NASDAQ:X... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.